1 completed, 1 unknown. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Tolcapone 200 MG: new trials by email Literature Review of Tolcapone 200 MG trials Research Report on Tolcapone 200 MG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tolcapone in Obsessive Compulsive Disorder Tolcapone 200 MG - Obsessive-Compulsive Disorder | Phase 2 / Phase 3 | Completed | University of Chicago | 20 | 2018-03-20 | 2022-04-07 |
| A Trial Evaluating Effects of COMT Inhibition in Patients With Acquired Brain Injury Tolcapone 200 MG, Placebo - Brain Injuries, Brain Injuries, Traumatic | Phase 2 | Unknown | Sheppard Pratt Health System | 16 | 2017-07-20 | 2017-09-06 |
Brain Injuries (1) · Brain Injuries, Traumatic (1) · Brain Injury, Chronic (1) · Obsessive-Compulsive Disorder (1)
Sheppard Pratt Health System (1) · University of Chicago (1)
United States (2)